Main Navigation


Quick Links


GPX Embolic Device Success in Challenging Tumor Case

Categories:

Fluidx Medical’s Novel Embolic Device Demonstrates Repeated Success in Treating Complex Tumors Fluidx Medical’s GPX Embolic Device was used to effectively devascularize a large tumor with multiple feeding vessels as part of a multi-center clinical trial. “This could have been a challenging case since it involved a large renal tumor fed by small, low flow, […]

Read More

Gentex Showcases Interiors Technology at CES 2022

Categories:

At CES 2022, Gentex displays multiple technologies focused on driver and cabin monitoring as well as new convenience features that will help automakers sell cars. Gentex acquired Vaporsens (a University of Utah Start up) in April 2020 and is using that company’s nanofiber chemical-sensing technology in a sensor that can be installed in a vehicle’s […]

Read More

Salarius Acquires Protein Degradation Portfolio from Deuterx to Advance Cancer Therapies

Categories:

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with sarcomas, pediatric cancers, and other cancers, today announced a definitive agreement with DeuteRx, LLC to acquire an oral, small molecule targeted protein degradation portfolio. The acquisition includes a lead drug candidate that Salarius has renamed SP-3164 (formerly DRX-164), the related patent family, including […]

Read More

2022 BioHive Entrepreneur & Investor Life Science Summit

Categories:

UTAH’S PREMIER EVENT FOR INVESTMENT IN THE LIFE SCIENCES INDUSTRY We’ll be back in person for the 2022 BioHive Entrepreneur & Investor Life Sciences Summit. Join us at the Summit to hear industry experts speak on compelling topics such as funding, operating and developing life sciences companies on March 9-10, 2021. Don’t miss this chance […]

Read More

The University of Utah Celebrates Innovation: Successful P3s and precedent-setting $884 million in Investments Raised by U Startup Companies

Categories:

In publishing the FY21 Innovation Report  the University of Utah’s (the U) PIVOT Center highlights several important partnerships, including Recursion and RenalytixAI. The report also celebrates some of the U’s innovation by promoting quantitative and qualitative metrics, such as the precedent-setting $884 million in investments raised by U startup companies; and technologies developed by University of […]

Read More

Child Care is Getting More Support From Some Private Companies

Categories:

University of Utah start up Recursion Pharmaceuticals created an on-site center for its headquarters in Salt Lake City, Utah. It launched in July. Heather Kirkby, chief people officer at Recursion, says it was a resource their CEO Chris Gibson wanted all the employees to have when he founded the company in 2015. Read the Full […]

Read More

Carterra and PerkinElmer Sign Distribution Agreement For Asia-Pacific and Oceania Region for Carterra’s High Throughput Antibody Screening and Characterization Solutions

Categories:

Carterra, Inc. the world leader in label-free high throughput antibody screening and characterization, today announced that it has signed an exclusive Asia-Pacific and Oceania region distribution agreement with PerkinElmer, Inc. a global leader committed to innovating for a healthier world.  With the agreement, PerkinElmer will market, sell, and service Carterra’s flagship LSA high-throughput surface plasmon resonance (SPR) platform and […]

Read More

Recursion signs partnership that could net company billions

Categories:

Recursion Pharmaceuticals Inc. has announced it has formed a drug-discovery collaboration with Swiss drug and diagnostics giant Roche AG, and its U.S. subsidiary Genentech, that is potentially worth several billion dollars to the Salt Lake City-based clinical-stage biotechnology company in the next 10 years. Recursion said it will work with the research and development units […]

Read More